OpenURL Connection Search

Select item for more details and to access through your institution.

Application of an artificial intelligence-based system in the diagnosis of breast ultrasound images obtained using a smartphone.
Published in:
World Journal of Surgical Oncology, 2024, v. 22, p. 1, doi. 10.1186/s12957-023-03286-1
By:
- Mori, Ryutaro;
- Okawa, Mai;
- Tokumaru, Yoshihisa;
- Niwa, Yoshimi;
- Matsuhashi, Nobuhisa;
- Futamura, Manabu
Publication type:
Article
High-speed atomic oxygen irradiation of atomically thin graphene for astronomical applications.
Published in:
Journal of Astronomical Telescopes, Instruments & Systems, 2024, v. 10, n. 2, p. 26006, doi. 10.1117/1.JATIS.10.2.026006
By:
- Kashiwakura, Kazuto;
- Mitsuishi, Ikuyuki;
- Hirota, Midori;
- Niwa, Yoshimi;
- Tawara, Yuzuru;
- Kitaura, Ryo;
- Omachi, Haruka;
- Tagawa, Masahito;
- Nomoto, Kentaro;
- Tsuruoka, Kazuyuki;
- Kawahara, Kenji;
- Ago, Hiroki
Publication type:
Article
Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer.
Published in:
Oncologist, 2024, v. 29, n. 6, p. e741, doi. 10.1093/oncolo/oyae015
By:
- Takahashi, Kaori;
- Uozumi, Ryuji;
- Mukohara, Toru;
- Hayashida, Tetsu;
- Iwabe, Midori;
- Iihara, Hirotoshi;
- Kusuhara-Mamishin, Kanako;
- Kitagawa, Yuko;
- Tsuchiya, Masami;
- Kitahora, Mika;
- Nagayama, Aiko;
- Kosaka, Shinkichi;
- Asano-Niwa, Yoshimi;
- Seki, Tomoko;
- Ohnuki, Koji;
- Suzuki, Akio;
- Ono, Fumiko;
- Futamura, Manabu;
- Kawazoe, Hitoshi;
- Nakamura, Tomonori
Publication type:
Article
The mechanism underlying resistance to 5-fluorouracil and its reversal by the inhibition of thymidine phosphorylase in breast cancer cells.
Published in:
Oncology Letters, 2022, v. 24, n. 3, p. N.PAG, doi. 10.3892/ol.2022.13431
By:
- Mori, Ryutaro;
- Ukai, Junko;
- Tokumaru, Yoshihisa;
- Niwa, Yoshimi;
- Futamura, Manabu
Publication type:
Article
Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study.
Published in:
Journal of Cancer, 2023, v. 14, n. 14, p. 2644, doi. 10.7150/jca.87169
By:
- Hirotoshi Iihara;
- Mototsugu Shimokawa;
- Hiroko Bando;
- Yoshimi Niwa;
- Yutaka Mizuno;
- Yoshihiro Kawaguchi;
- Mika Kitahora;
- Akari Murakami;
- Masaaki Kawai;
- Kazushige Ishida;
- Makoto Takeuchi;
- Kazuhiro Ishihara;
- Tomokazu Iyoda;
- Takumi Nakada;
- Atsuko Ogiso;
- Yasuyuki Kojima;
- Fumiyoshi Kumagai;
- Aya Sawa;
- Ryutaro Mori;
- Kosuke Higuchi
Publication type:
Article
Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a multicenter phase II clinical trial (PerSeUS-BC04).
Published in:
Breast Cancer (13406868), 2023, v. 30, n. 2, p. 293, doi. 10.1007/s12282-022-01425-2
By:
- Futamura, Manabu;
- Ishihara, Kazuhiro;
- Nagao, Yasuko;
- Ogiso, Atsuko;
- Niwa, Yoshimi;
- Nakada, Takumi;
- Kawaguchi, Yoshihiro;
- Ikawa, Ai;
- Kumazawa, Iwao;
- Mori, Ryutaro;
- Kitazawa, Mai;
- Hosono, Yoshiki;
- Kuno, Masashi;
- Kawajiri, Mana;
- Nakakami, Akira;
- Takeuchi, Makoto;
- Morikawa, Akemi;
- Tokumaru, Yoshihisa;
- Katagiri, Yasuo;
- Asano, Yoshimasa
Publication type:
Article
CSL encodes a leucine-rich-repeat protein implicated in red/violet light signaling to the circadian clock in Chlamydomonas.
Published in:
PLoS Genetics, 2017, v. 13, n. 3, p. 1, doi. 10.1371/journal.pgen.1006645
By:
- Kinoshita, Ayumi;
- Niwa, Yoshimi;
- Onai, Kiyoshi;
- Yamano, Takashi;
- Fukuzawa, Hideya;
- Ishiura, Masahiro;
- Matsuo, Takuya
Publication type:
Article

Found: 7

Application of an artificial intelligence-based system in the diagnosis of breast ultrasound images obtained using a smartphone.

High-speed atomic oxygen irradiation of atomically thin graphene for astronomical applications.

Proton Pump Inhibitors and Cyclin-Dependent Kinase 4/6 Inhibitors in Patients With Breast Cancer.

The mechanism underlying resistance to 5-fluorouracil and its reversal by the inhibition of thymidine phosphorylase in breast cancer cells.

Doublet or Triplet Antiemetic Prophylaxis for Nausea and Vomiting Induced by Trastuzumab Deruxtecan: an Open-Label, Randomized, and Multicenter Exploratory Phase 2 Study.

Neoadjuvant chemotherapy using nanoparticle albumin-bound paclitaxel plus trastuzumab and pertuzumab followed by epirubicin and cyclophosphamide for operable HER2-positive primary breast cancer: a multicenter phase II clinical trial (PerSeUS-BC04).

CSL encodes a leucine-rich-repeat protein implicated in red/violet light signaling to the circadian clock in Chlamydomonas.